Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial

Summary Background In many patients with chronic lymphocytic leukaemia requiring treatment, induction therapy with rituximab plus chemotherapy improves outcomes compared with chemotherapy alone. In this study we aimed to investigate the potential of rituximab maintenance therapy to prolong disease c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet. Haematology 2016-07, Vol.3 (7), p.e317-e329
Hauptverfasser: Greil, Richard, Prof, Obrtlíková, Petra, MD, Smolej, Lukáš, MD, Kozák, Tomáš, Prof, Steurer, Michael, Prof, Andel, Johannes, MD, Burgstaller, Sonja, MD, Mikušková, Eva, MD, Gercheva, Liana, Prof, Nösslinger, Thomas, MD, Papajík, Tomáš, Prof, Ladická, Miriam, MD, Girschikofsky, Michael, MD, Hrubiško, Mikuláš, Prof, Jäger, Ulrich, Prof, Fridrik, Michael, MD, Pecherstorfer, Martin, Prof, Králiková, Eva, MD, Burcoveanu, Cristina, MD, Spasov, Emil, MD, Petzer, Andreas, Prof, Mihaylov, Georgi, MD, Raynov, Julian, MD, Oexle, Horst, MD, Zabernigg, August, MD, Flochová, Emília, MD, Palášthy, Stanislav, MD, Stehlíková, Olga, Doubek, Michael, Prof, Altenhofer, Petra, MD, Pleyer, Lisa, MD, Melchardt, Thomas, MD, Klingler, Anton, PhD, Mayer, Jiří, Prof, Egle, Alexander, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!